Association between the p73 G4C14-to-A4T14 polymorphism and risk of nasopharyngeal carcinoma: A case-control and family-based study

Carcinogenesis

Volumn 35, Issue 9, 2014, Pages 1977-1982

  Zhang, Xiaoai ^a,b   Cao, Pengbo ^a   Zhai, Yun ^a   Zhang, Hongxing ^a   Cui, Ying ^c   Wu, Zhihao ^a   Yuan, Xiaoyan ^a   Wang, Zhifu ^a   Li, Peiyao ^a   Yu, Lixa ^a   Xia, Xia ^a   He, Fuchu ^a   Zhou, Gangqiao ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c Guangxi Cancer Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ADULT; ADVANCED CANCER; ALLELE; APOPTOSIS; ARTICLE; CANCER FAMILY; CANCER RISK; CANCER SUSCEPTIBILITY; CANCER TISSUE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FAMILIAL CANCER; FAMILY STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; NICK END LABELING; P73 GENE; PARENTAGE ANALYSIS; PROGENY; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADULT; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; RISK FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84906832406     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu059     Document Type: Article

References (36)

1. Mould,R.F. et al. (2002) Nasopharyngeal carcinoma: treatments and outcomes in the 20th century. Br. J. Radiol., 75, 307-339.
2. Cho,W.C. (2007) Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Mol. Cancer, 6, 1.
3. He,Y. et al. (2005) Association of PLUNC gene polymorphisms with susceptibility to nasopharyngeal carcinoma in a Chinese population. J. Med. Genet., 42, 172-176.
4. Zhou,G. et al. (2007) Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma. Hum. Mutat., 28, 1091-1097.
5. Zhou,G. et al. (2007) MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population. Clin. Cancer Res., 13, 2627-2633.
6. Cao,Y. et al. (2010) Polymorphisms of methylenetetrahydrofolate reductase are associated with a high risk of nasopharyngeal carcinoma in a smoking population from Southern China. Mol. Carcinog., 49, 928-934.
7. Sheng,L. et al. (2013) ABO blood group and nasopharyngeal carcinoma risk in a population of Southeast China. Int. J. Cancer, 133, 893-897.
8. Kaghad,M. et al. (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90, 809-819.
9. Rufini,A. et al. (2011) p73 in Cancer. Genes Cancer, 2, 491-502.
10. Conforti,F. et al. (2012) Regulation of p73 activity by post-translational modifications. Cell Death Dis., 3, e285.
11. Nekulová,M. et al. (2010) Analysis of the intracellular localization of p73 N-terminal protein isoforms TAp73 and δNp73 in medulloblastoma cell lines. J. Mol. Histol., 41, 267-275.
12. Shao,J.Y. et al. (2000) Genome-wide allelotype analysis of sporadic primary nasopharyngeal carcinoma from southern China. Int. J. Oncol., 17, 1267-1275.
13. Li,G. et al. (2004) p73 G4C14-to-A4T14 polymorphism and risk of lung cancer. Cancer Res., 64, 6863-6866.
14. Li,G. et al. (2004) Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis, 25, 1911-1916.
15. Niwa,Y. et al. (2004) Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese. Cancer Lett., 205, 55-60.
16. Misra,C. et al. (2009) Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer. Mol. Carcinog., 48, 790-800.
17. Chen,X. et al. (2008) p73 G4C14-to-A4T14 polymorphism and risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never smokers and never drinkers. Cancer, 113, 3307-3314.
18. De Feo,E. et al. (2009) A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression. Mutat. Res., 675, 60-65.
19. Deng,B. et al. (2013) Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of hepatocellular carcinoma in a Chinese population. Tumour Biol., 34, 293-299.
20. Umar,M. et al. (2012) Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer: a case control study in a northern Indian population. Mol. Biol. Rep., 39, 1153-1162.
21. Zhou,X. (2013) p73 G4C14-to-A4T14 polymorphisms are positively correlated with triple-negative breast cancer in southwestern China. Med. Oncol., 30, 515.
22. Wang,Z. et al. (2012) Association of combined p73 and p53 genetic variants with tumor HPV16-positive oropharyngeal cancer. PLoS One, 7, e35522.
23. Zhou,X. et al. (2012) Association of p73 G4C14-A4T14 polymorphisms with genetic susceptibilities to breast cancer: a case-control study. Med. Oncol., 29, 3216-3221.
24. Mittal,R.D. et al. (2011) Role of functional polymorphisms of P53 and P73 genes with the risk of prostate cancer in a case-control study from Northern India. Arch. Med. Res., 42, 122-127.
25. Zhang,X. et al. (2012) The p73 G4C14-to-A4T14 polymorphism is associated with risk of lung cancer in the Han nationality of North China. Mol. Carcinog, 52, 387-91.
26. Stiewe,T. et al. (2004) Quantitative TP73 transcript analysis in hepatocellular carcinomas. Clin. Cancer Res., 10, 626-633.
27. Adams,M.J. Jr et al. (1989) The use of attributable fraction in the design and interpretation of epidemiologic studies. J. Clin. Epidemiol., 42, 659-662.
28. Di Vinci,A. et al. (2009) Different intracellular compartmentalization of TA and DeltaNp73 in non-small cell lung cancer. Int. J. Oncol., 34, 449-456.
29. Tomasini,R. et al. (2008) TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev., 22, 2677-2691.
30. Blanch,A. et al. (2013) Eukaryotic translation elongation factor 1-alpha 1 inhibits p53 and p73 dependent apoptosis and chemotherapy sensitivity. PLoS One, 8, e66436.
31. Li,J. et al. (2000) [Apoptosis and apoptosis-related gene expression in nasopharyngeal carcinoma]. Zhonghua Zhong Liu Za Zhi, 22, 158-160.
32. Lee,J.W. et al. (2010) Widespread expression of prostate apoptosis response-4 in nasopharyngeal carcinoma. Head Neck, 32, 877-885.
33. Huang,X.E. et al. (2003) Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer. Breast Cancer, 10, 307-311.
34. Hamajima,N. et al. (2002) No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Lett., 181, 81-85.
35. Hu,Z. et al. (2005) Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population. Int. J. Cancer, 114, 455-460.
36. Ryan,B.M. et al. (2001) A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma. Br. J. Cancer, 85, 1499-1503.